Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.

Authors:
Amy K Forrestel
Amy K Forrestel
Yale University School of Medicine
United States
Badri G Modi
Badri G Modi
Yale University School of Medicine
United States
Sarah Longworth
Sarah Longworth
University of Pennsylvania
Tempe | United States
Marissa B Wilck
Marissa B Wilck
Brigham and Women's Hospital
United States
Robert G Micheletti
Robert G Micheletti
Perelman School of Medicine at the University of Pennsylvania

JAMA Neurol 2016 Mar;73(3):355-6

Department of Dermatology, University of Pennsylvania, Philadelphia.

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.4259DOI Listing
March 2016
5 Reads

Publication Analysis

Top Keywords

cryptococcus patient
4
sclerosis treated
4
patient multiple
4
multiple sclerosis
4
cutaneous cryptococcus
4
primary cutaneous
4
treated fingolimod
4
treated
1
fingolimod
1
multiple
1
cryptococcus
1
patient
1
primary
1
sclerosis
1

Similar Publications

Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod.

Intern Med 2016;55(22):3383-3386. Epub 2016 Nov 15.

Department of General Internal Medicine, Kobe University Hospital, Japan.

We herein report the case of a 63-year-old man who presented with a 3-month history of a cutaneous nodular lesion of his jaw, low grade fever, lethargy and progressive cognitive impairment. He had a 30-year history of multiple sclerosis and had been treated with fingolimod for the previous 2 years. Laboratory data revealed CD4 lymphocytopenia and a tissue culture of the skin nodule was positive for Cryptococcus neoformans. Read More

View Article
February 2017

Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections?

Mult Scler 2017 Feb;23(2):297-299

St Croix Dermatology, Stillwater, MN, USA.

Background: Fingolimod is an oral disease-modifying therapy for relapsing forms of multiple sclerosis, which acts by sequestering lymphocytes within lymph nodes.

Objective: To describe a case of extrapulmonary cryptococcosis in a patient taking fingolimod.

Methods: Case report. Read More

View Article
February 2017

Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.

Mult Scler 2015 May 28;21(6):795-6. Epub 2014 Nov 28.

Department of Neurology, NIMTS Hospital, Athens, Greece.

View Article
May 2015

Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.

Authors:
DeRen Huang

Neurology 2015 Sep 19;85(11):1001-3. Epub 2015 Aug 19.

From the Multiple Sclerosis Center, Neurology and Neuroscience Associates, Unity Health Network, Akron, OH.

View Article
September 2015